Ethylene Glycol

Ethylene Glycol

SCHEMBL3259231

CCCCCCCCc1ccccc1Oc1ccccc1CCCCCCCC.OCCO

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
THRA P10827 1/20 0.56
THRB P10828 1/20 0.56
LIPG Q9Y5X9 1/20 0.54
ALOX5 P09917 1/20 0.53
PTGS2 P35354 1/20 0.53
PPARA Q07869 2/20 0.50
PPARG P37231 1/20 0.48
BID P55957 3/20 0.43
MCL1 Q07820 3/20 0.43
BCL2L1 Q07817 2/20 0.43
BAK1 Q16611 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene Glycol SCHEMBL20582190 1.00 THRA (0.56) THRATHRBLIPGALOX5PTGS2
Ethylene Glycol SCHEMBL11574529 1.00 THRA (0.56) THRATHRBLIPGALOX5PTGS2
Ethylene Glycol SCHEMBL487727 1.00 THRA (0.56) THRATHRBLIPGALOX5PTGS2
Ethylene Glycol SCHEMBL11667182 0.97 THRA (0.57) THRATHRBLIPGALOX5PTGS2
Ethylene Glycol SCHEMBL21373973 0.97 THRA (0.57) THRATHRBLIPGALOX5PTGS2
Ethylene Glycol SCHEMBL1508679 0.97 THRA (0.57) THRATHRBLIPGALOX5PTGS2
Ethylene Glycol SCHEMBL11666399 0.97 THRA (0.57) THRATHRBLIPGALOX5PTGS2
Ethylene Glycol SCHEMBL11057177 0.97 THRA (0.57) THRATHRBLIPGALOX5PTGS2
Ethylene Glycol SCHEMBL2169345 0.97 THRA (0.57) THRATHRBLIPGALOX5PTGS2
Ethylene Glycol SCHEMBL1798524 0.93 THRA (0.48) THRATHRBLIPGALOX5PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 344 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113403298-B Immobilization method of free enzyme 万华化学集团股份有限公司 2024-02-27 CN claimed
CN-117417978-A Virus lysate, preparation method and application thereof 合肥善本生物科技有限公司 2024-01-19 CN claimed
CN-116532653-B Silver powder for SLM powder spreading, printing and forming and preparation method thereof 长春黄金研究院有限公司 2023-09-05 CN claimed
CN-116532653-A Silver powder for SLM powder spreading, printing and forming and preparation method thereof 长春黄金研究院有限公司 2023-08-04 CN claimed
CN-115058055-A Cystamine modified functionalized magnetic material and preparation method and application thereof 中国医学科学院基础医学研究所 2022-09-16 CN claimed
CN-106566412-B Silicon-containing layer stopping additive 弗萨姆材料美国有限责任公司 2022-09-06 CN claimed
WO-2021161064-A1 CORE/SHELL MICROCAPSULES AND A METHOD FOR THE FABRICATION OF CORE/SHELL MICROCAPSULES POLITECHNIKA WARSZAWSKA (PL) 2021-08-19 WO claimed
EP-3500099-A1 USE OF COMPOSITIONS COMPRISING PELARGONIC ACID AND SPECIFIC NON IONIC SURFACTANTS FOR INHIBITING THE GROWTH OF SUCKERS ON PLANTS Belchim Crop Protection NV (BE) 2019-06-26 EP claimed
WO-2018033617-A1 USE OF COMPOSITIONS COMPRISING PELARGONIC ACID AND SPECIFIC NON IONIC SURFACTANTS FOR INHIBITING THE GROWTH OF SUCKERS ON PLANTS BELCHIM CROP PROTECTION NV (BE) 2018-02-22 WO claimed
CN-114913062-B Super-resolution image reconstruction method and system based on position-related point spread function 复旦大学 2024-10-22 CN disclosed
CN-118434748-A Six-membered and six-membered compound, preparation method, pharmaceutical composition and application 杭州多域生物技术有限公司 2024-08-02 CN disclosed
US-12042539-B2 Compositions and kits for Omeprazole suspension AZURITY PHARMACEUTICALS, INC. (US) 2024-07-23 US disclosed
CN-118339244-A Triazolyl and/or triazolium-based polymers and copolymers as additives for chemical mechanical planarization slurries 弗萨姆材料美国有限责任公司 2024-07-12 CN disclosed
US-12031085-B2 Manganese oxide sulfide capture drilling fluid KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2024-07-09 US disclosed
CN-1410383-A Cement paste antiadhesion agent and its making method SHANGHAI UNIV OF ENGINEERING T (CN) 2003-04-16 CN disclosed
EP-1084396-A1 ELECTROPHORESIS APPARATUS AND METHOD LYNX THERAPEUTICS, INC. (US) 2001-03-21 EP disclosed
WO-1999061901-A1 ELECTROPHORESIS APPARATUS AND METHOD LYNX THERAPEUTICS, INC. (US) 1999-12-02 WO disclosed
US-5952410-A POLYACETAL RESIN CONSISTS OF ATLEAST ONE BISAMIDE COMPOUND; EXCELLENT RESISTANCE TO COOLING-HEATING CYCLES, SHELF-LIFE, STORAGE STABILITY WITHOUT CRAZING OR CRACKING ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1999-09-14 US disclosed
CN-1212833-A Method for preparing agricultural chemical for prevention and control of vegetable Liriomyza munda UNIV SHANDONG AGRICULTURAL (CN) 1999-04-07 CN disclosed
US-5547833-A Radial flow assay, delivering member, test kit, and methods INTRACEL CORPORATION (US) 1996-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12042539-B2 Compositions and kits for Omeprazole suspension PGA5, ATP6V1G1, MLN THRA 4560/4885THRB 4714/4885LIPG 639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.